Enzymatic reaction generates novel pyrazino[1,2-a]indole, with notable antiplasmodial and antitumor activity, indicating McbB's unique specificity.
Rational substrate exploration with enzymes can unlock innovative molecular architectures and reveal unprecedented biological activities. Inspired by our previous studies on strictosidine synthase, a plant-derived Pictet-Spenglerase, we designed (S)-2-amino-3-(1H-indol-1-yl)propionic acid (1) as a novel substrate for the microbial Pictet-Spenglerase McbB. Enzymatic condensation of 1 with oxaloacetaldehyde afforded the rare pyrazino[1,2-a]indole scaffold, overcoming both intrinsic β-carboline bias and the limitations of conventional chemical Pictet-Spengler reactions. Substrate profiling revealed that McbB exhibited strict specificity for 4-methyl- and 5-fluoro-substituted analogs of 1, yet tolerated methylglyoxal or formaldehyde as aldehyde partners with 1. Site-directed mutagenesis combined with computational docking delineated a new substrate binding mode and provided insights into the catalytic mechanism. Further chemoenzymatic derivatization of 1 yielded novel pyrazino[1,2-a]indoles with notable antiplasmodial (compound 12, IC50 = 1.5 ± 0.2 μM vs P.f. 3D7) and antitumor activities (compound 13, IC50 = 3.19 ± 0.3 μM vs HL60). This study expands our understanding of the enzymatic mechanism of McbB and enables the development of diverse bioactive compounds through substrate exploration.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: